Current SARS-CoV-2 Omicron subvariants impose a heavy burden on global health systems
by evading immunity from most developed neutralizing antibodies and vaccines. Here, we …

SARS-CoV-2 variants with adaptive mutations have continued to emerge, causing fresh
waves of infection even amongst vaccinated population. The development of broad-spectrum …

Human monkeypox (MPX) is a rare zoonotic infection characterized by smallpox-like signs
and symptoms. It is caused by monkeypox virus (MPXV), a double stranded DNA virus …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still rapidly spreading
worldwide. Many drugs and vaccines have been approved for clinical use show efficacy in the …

Nipah virus (NiV) is a highly lethal zoonotic paramyxovirus that poses a severe threat to
humans due to its high morbidity and the lack of viable countermeasures. Vaccines are the most …

The ongoing pandemic caused by mpox virus (MPXV) has become an international public
health emergency that poses a significant threat to global health. The vaccinia virus Tiantan …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron and its subvariants
(such as BQ.1, XBB and the latest variants, including XBB.1.16, EG.5, and BA.2.86), as …

Dear Editor, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected
more than 400 million people globally, resulting in millions of deaths. 1 As the virus evolves, a …

Major diseases, such as cancer and COVID‐19, are frightening global health problems, and
sustained action is necessary to develop vaccines. Here, for the first time, ethoxy acetalated …

Nipah virus (NiV) is a World Health Organization priority pathogen and there are currently
no approved drugs for clinical immunotherapy. Through the use of a naïve human phage-…